Abu-Elmagd K, Fung J J, Reyes J, Casavilla A, Van Thiel D H, Iwaki Y, Warty V, Nikolaidis N, Block J, Nakamura K
Department of Surgery, University of Pittsburgh, Pennsylvania 15213.
Transplant Proc. 1992 Jun;24(3):1243-4.
We report here the clinical experience and management guidelines for the nine consecutive cases who received either an isolated small intestinal graft (n = 1) or an intestine liver combination at the University of Pittsburgh, with FK 506 being the basic immunosuppressive drug therapy.
我们在此报告匹兹堡大学连续9例接受孤立小肠移植(n = 1)或小肠-肝脏联合移植患者的临床经验及管理指南,其中以FK 506作为基本免疫抑制药物疗法。